STERIS plc
STENYSEHealthcare● Active
$210.88
$-1.48(-0.69%)
Market Cap$20.6B
P/E Ratio—
52W High$269.44
52W Low$195.14
STERIS plc (STE) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
STE · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 11, 2026EPS Actual
$2.83
Est. $2.85 · -0.7%
Revenue
$1.59B
Est. $1.59B · -0.4%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 11, 2026
After Market Close
STE reports quarterly as a NYSE-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.49B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.49B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 5, 2026 | $2.52 | — | — | — | $1.50B | — |
| — Q2 FY2026 | May 11, 2026 | $2.85 | $2.83 | -0.7% | $1.59B | $1.59B | -0.4% |
| — Q1 FY2026 | Feb 4, 2026 | $2.53 | $2.53 | +0.0% | $1.50B | $1.48B | +1.0% |
| ▲ Q4 FY2025 | Nov 5, 2025 | $2.35 | $2.47 | +5.1% | $1.46B | $1.43B | +2.0% |
| ▲ Q3 FY2025 | Aug 6, 2025 | $2.26 | $2.34 | +3.5% | $1.39B | $1.36B | +2.1% |
| ▲ Q2 FY2025 | May 14, 2025 | $2.60 | $2.74 | +5.4% | $1.48B | $1.47B | +0.8% |
| — Q1 FY2025 | Feb 5, 2025 | $2.33 | $2.32 | -0.4% | $1.37B | $1.38B | -0.8% |
| — Q4 FY2024 | Nov 6, 2024 | $2.12 | $2.14 | +0.9% | $1.33B | $1.33B | -0.1% |
Q3 FY2026
Aug 5, 2026
EPS Actual
—
EPS Est.
$2.52
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 11, 2026
EPS Actual
$2.83
EPS Est.
$2.85
EPS Surpr.
-0.7%
Revenue
$1.59B
Q1 FY2026
Feb 4, 2026
EPS Actual
$2.53
EPS Est.
$2.53
EPS Surpr.
+0.0%
Revenue
$1.50B
Q4 FY2025
Nov 5, 2025Beat
EPS Actual
$2.47
EPS Est.
$2.35
EPS Surpr.
+5.1%
Revenue
$1.46B
Q3 FY2025
Aug 6, 2025Beat
EPS Actual
$2.34
EPS Est.
$2.26
EPS Surpr.
+3.5%
Revenue
$1.39B
Q2 FY2025
May 14, 2025Beat
EPS Actual
$2.74
EPS Est.
$2.60
EPS Surpr.
+5.4%
Revenue
$1.48B
Q1 FY2025
Feb 5, 2025
EPS Actual
$2.32
EPS Est.
$2.33
EPS Surpr.
-0.4%
Revenue
$1.37B
Q4 FY2024
Nov 6, 2024
EPS Actual
$2.14
EPS Est.
$2.12
EPS Surpr.
+0.9%
Revenue
$1.33B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2028 | $3.40 | $3.43 | $3.46 | 3 |
| Q4 FY2027 | $3.03 | $3.06 | $3.09 | 2 |
| Q3 FY2027 | $2.92 | $2.95 | $2.97 | 1 |
| Q2 FY2027 | $2.73 | $2.76 | $2.78 | 1 |
| Q1 FY2027 | $3.12 | $3.15 | $3.18 | 2 |
| Q4 FY2026 | $2.78 | $2.80 | $2.83 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2028 | $1.8B | $1.8B | $1.8B | 2 |
| Q4 FY2027 | $1.7B | $1.7B | $1.7B | 3 |
| Q3 FY2027 | $1.6B | $1.7B | $1.7B | 2 |
| Q2 FY2027 | $1.6B | $1.6B | $1.6B | 2 |
| Q1 FY2027 | $1.7B | $1.7B | $1.7B | 3 |
| Q4 FY2026 | $1.6B | $1.6B | $1.6B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 11, 2026 | -0.7% | $207.45 | $201.85 | -2.70% |
| ▲ Q1 FY2026 | Feb 4, 2026 | +0.0% | $261.67 | $264.27 | +0.99% |
| ▲ Q4 FY2025 | Nov 5, 2025 | +5.1% | $241.85 | $243.18 | +0.55% |
| ▲ Q3 FY2025 | Aug 6, 2025 | +3.5% | $223.87 | $221.21 | -1.19% |
| ▲ Q2 FY2025 | May 14, 2025 | +5.4% | $231.15 | $227.50 | -1.58% |
| ▲ Q1 FY2025 | Feb 5, 2025 | -0.4% | $219.40 | $220.83 | +0.65% |
| ▲ Q4 FY2024 | Nov 6, 2024 | +0.9% | $227.44 | $227.52 | +0.04% |
| ▲ Q3 FY2024 | Aug 6, 2024 | +2.5% | $237.90 | $239.18 | +0.54% |
Q2 FY2026-2.70%
Report Date
May 11, 2026
EPS Beat/Miss
-0.7%
Price Before
$207.45
Price After
$201.85
Q1 FY2026+0.99%
Report Date
Feb 4, 2026
EPS Beat/Miss
+0.0%
Price Before
$261.67
Price After
$264.27
Q4 FY2025+0.55%
Report Date
Nov 5, 2025
EPS Beat/Miss
+5.1%
Price Before
$241.85
Price After
$243.18
Q3 FY2025-1.19%
Report Date
Aug 6, 2025
EPS Beat/Miss
+3.5%
Price Before
$223.87
Price After
$221.21
Q2 FY2025-1.58%
Report Date
May 14, 2025
EPS Beat/Miss
+5.4%
Price Before
$231.15
Price After
$227.50
Q1 FY2025+0.65%
Report Date
Feb 5, 2025
EPS Beat/Miss
-0.4%
Price Before
$219.40
Price After
$220.83
Q4 FY2024+0.04%
Report Date
Nov 6, 2024
EPS Beat/Miss
+0.9%
Price Before
$227.44
Price After
$227.52
Q3 FY2024+0.54%
Report Date
Aug 6, 2024
EPS Beat/Miss
+2.5%
Price Before
$237.90
Price After
$239.18
Avg Beat Reaction-0.34%
Beat Rate8 / 8 quarters
Largest Move-2.70% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: STE ends December
STERIS plc (STE) most recently reported earnings on May 11, 2026 for Q2 FY2026, posting EPS of $2.83 (in line with the analyst consensus of $2.85). The next STE earnings date is expected around September 1, 2026.
Each quarter, investors track STE earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. STE revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
STE's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
STE earnings · 4 questionsSTERIS plc's next earnings report is expected around September 1, 2026. STE typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; STE historically reports after market close (AMC).
STE earnings datewhen is STE earningsSTE next earnings datewhen does STE report earningsSTE earnings calendar
▸ Source: FMP · STERIS plc SEC filings · US GAAP · STERIS plc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026